Advertisement

Executive summary: Workshop on Preeclampsia, January 25–26, 2021, cosponsored by the Society for Maternal-Fetal Medicine and the Preeclampsia Foundation

  • Society for Maternal-Fetal Medicine (SMFM)
      Preeclampsia is a substantial cause of maternal and perinatal morbidity and mortality. The prevalence of this condition has increased over the past several decades.
      • Wallis A.B.
      • Saftlas A.F.
      • Hsia J.
      • Atrash H.K.
      Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987–2004.
      ,
      • Rana S.
      • Lemoine E.
      • Granger J.P.
      • Karumanchi S.A.
      Preeclampsia: pathophysiology, challenges, and perspectives.
      Additional opportunities are needed to foster interdisciplinary collaborations and improve patient care in the setting of preeclampsia. In recognition of the Preeclampsia Foundation’s 20th anniversary and its work to advance preeclampsia research and clinical agendas, a 2-day workshop on preeclampsia was cosponsored by the Society for Maternal-Fetal Medicine and the Preeclampsia Foundation and held in conjunction with the 41st Annual Pregnancy Meeting. Leaders with expertise in preeclampsia research, obstetrical care, primary care medicine, cardiology, endocrinology, and patient advocacy gathered to discuss preeclampsia prediction, prevention, management, and long-term impacts. The goals of the workshop were to review existing knowledge and create consensus concerning research and clinical priorities:
      • To present innovative opportunities for research on predicting, preventing, and managing preeclampsia
      • To review benefits and challenges associated with various strategies for prediction, prevention, and management of preeclampsia
      • To identify research gaps for the prediction, prevention, and management of preeclampsia
      • To discuss needs and opportunities for research, increasing awareness, and risk mitigation of the long-term impacts of preeclampsia
      To read this article in full you will need to make a payment

      Subscribe:

      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Wallis A.B.
        • Saftlas A.F.
        • Hsia J.
        • Atrash H.K.
        Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987–2004.
        Am J Hypertens. 2008; 21: 521-526
        • Rana S.
        • Lemoine E.
        • Granger J.P.
        • Karumanchi S.A.
        Preeclampsia: pathophysiology, challenges, and perspectives.
        Circ Res. 2019; 124: 1094-1112
        • Say L.
        • Chou D.
        • Gemmill A.
        • et al.
        Global causes of maternal death: a WHO systematic analysis.
        Lancet Glob Health. 2014; 2: e323-e333
        • Bilano V.L.
        • Ota E.
        • Ganchimeg T.
        • Mori R.
        • Souza J.P.
        Risk factors of pre-eclampsia/eclampsia and its adverse outcomes in low- and middle-income countries: a WHO secondary analysis.
        PLoS One. 2014; 9: e91198
        • Lieberman A.
        Challenges for maternal health efforts.
        Lancet. 2016; 388: 1146-1147
        • Ndwiga C.
        • Sripad P.
        • Warren C.E.
        Addressing barriers to quality of underutilized commodities and services for prevention and management of preeclampsia and eclampsia in Kenya.
        (Available at:) (Accessed June 16, 2021)
        • Petersen E.E.
        • Davis N.L.
        • Goodman D.
        • et al.
        Vital signs: pregnancy-related deaths, United States, 2011-2015, and strategies for prevention, 13 states, 2013-2017.
        MMWR Morb Mortal Wkly Rep. 2019; 68: 423-429
        • Hauspurg A.
        • Lemon L.
        • Cabrera C.
        • et al.
        Racial differences in postpartum blood pressure trajectories among women after a hypertensive disorder of pregnancy.
        JAMA Netw Open. 2020; 3e2030815
      1. Stuart JJ. The impact of preeclampsia on long-term mental health. Oral presentation at: Preeclampsia Workshop; 41st Annual Pregnancy Meeting; January 25, 2021; Virtual.

        • Facco F.L.
        • Parker C.B.
        • Reddy U.M.
        • et al.
        Association between sleep-disordered breathing and hypertensive disorders of pregnancy and gestational diabetes mellitus.
        Obstet Gynecol. 2017; 129: 31-41
        • Grandi S.M.
        • Filion K.B.
        • Yoon S.
        • et al.
        Cardiovascular disease-related morbidity and mortality in women with a history of pregnancy complications.
        Circulation. 2019; 139: 1069-1079
        • Maher G.M.
        • O’Keeffe G.W.
        • Kearney P.M.
        • et al.
        Association of hypertensive disorders of pregnancy with risk of neurodevelopmental disorders in offspring: a systematic review and meta-analysis.
        JAMA Psychiatry. 2018; 75: 809-819
        • Sun B.Z.
        • Moster D.
        • Harmon Q.E.
        • Wilcox A.J.
        Association of preeclampsia in term births with neurodevelopmental disorders in offspring.
        JAMA Psychiatry. 2020; 77: 823-829
      2. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators.
        Hepatology. 1998; 28: 751-755
        • Brown M.A.
        • Magee L.A.
        • Kenny L.C.
        • et al.
        The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice.
        Pregnancy Hypertens. 2018; 13: 291-310
        • Magee L.A.
        • Pels A.
        • Helewa M.
        • Rey E.
        • von Dadelszen P.
        • Canadian Hypertensive Disorders of Pregnancy (HDP) Working Group
        Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy.
        Pregnancy Hypertens. 2014; 4: 105-145
      3. Gestational hypertension and preeclampsia: ACOG Practice Bulletin, number 222.
        Obstet Gynecol. 2020; 135: e237-e260
        • Chaiworapongsa T.
        • Chaemsaithong P.
        • Yeo L.
        • Romero R.
        Pre-eclampsia part 1: current understanding of its pathophysiology.
        Nat Rev Nephrol. 2014; 10: 466-480
        • Leavey K.
        • Benton S.J.
        • Grynspan D.
        • Kingdom J.C.
        • Bainbridge S.A.
        • Cox B.J.
        Unsupervised placental gene expression profiling identifies clinically relevant subclasses of human preeclampsia.
        Hypertension. 2016; 68: 137-147
        • Myatt L.
        The prediction of preeclampsia: the way forward.
        Am J Obstet Gynecol. 2020; ([Epub ahead of print])
        • Zhang B.
        • Kim M.Y.
        • Elliot G.
        • et al.
        Human placental cytotrophoblast epigenome dynamics over gestation and alterations in placental disease.
        Dev Cell. 2021; 56: 1238-1252.e5
        • Ghaemi M.S.
        • Tarca A.L.
        • Romero R.
        • et al.
        Proteomic signatures predict preeclampsia in individual cohorts but not across cohorts - implications for clinical biomarker studies.
        J Matern Fetal Neonatal Med. 2021; ([Epub ahead of print])
        • Parchem J.G.
        • Brock C.O.
        • Chen H.Y.
        • et al.
        Placental growth factor and the risk of adverse neonatal and maternal outcomes.
        Obstet Gynecol. 2020; 135: 665-673
        • Rood K.M.
        • Buhimschi C.S.
        • Dible T.
        • et al.
        Congo red dot paper test for antenatal triage and rapid identification of preeclampsia.
        EClinicalMedicine. 2019; 8: 47-56
        • Poon L.C.Y.
        • Akolekar R.
        • Lachmann R.
        • Beta J.
        • Nicolaides K.H.
        Hypertensive disorders in pregnancy: screening by biophysical and biochemical markers at 11-13 weeks.
        Ultrasound Obstet Gynecol. 2010; 35: 662-670
        • Poon L.C.
        • Shennan A.
        • Hyett J.A.
        • et al.
        The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention.
        Int J Gynecol Obstet. 2019; 145: 1-33
        • McGinnis R.
        • Steinthorsdottir V.
        • Williams N.O.
        • et al.
        Variants in the fetal genome near FLT1 are associated with risk of preeclampsia.
        Nat Genet. 2017; 49: 1255-1260
        • Steinthorsdottir V.
        • McGinnis R.
        • Williams N.O.
        • et al.
        Genetic predisposition to hypertension is associated with preeclampsia in European and Central Asian women.
        Nat Commun. 2020; 11: 5976
        • LeFevre M.L.
        • U.S. Preventive Services Task Force
        Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement.
        Ann Intern Med. 2014; 161: 819-826
        • Mone F.
        • O’Mahony J.F.
        • Tyrrell E.
        • et al.
        Preeclampsia prevention using routine versus screening test-indicated aspirin in low-risk women.
        Hypertension. 2018; 72: 1391-1396
        • Ahmed A.
        • Williams D.J.
        • Cheed V.
        • et al.
        Pravastatin for early-onset pre-eclampsia: a randomised, blinded, placebo-controlled trial.
        BJOG. 2020; 127: 478-488
        • Thadhani R.
        • Hagmann H.
        • Schaarschmidt W.
        • et al.
        Removal of soluble fms-like tyrosine kinase-1 by dextran sulfate apheresis in preeclampsia.
        J Am Soc Nephrol. 2016; 27: 903-913
        • Thadhani R.
        • Kisner T.
        • Hagmann H.
        • et al.
        Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia.
        Circulation. 2011; 124: 940-950
        • Anness A.R.
        • Baldo A.
        • Webb D.R.
        • Khalil A.
        • Robinson T.G.
        • Mousa H.A.
        Effect of metformin on biomarkers of placental- mediated disease: a systematic review and meta-analysis.
        Placenta. 2021; 107: 51-58
        • Cluver C.A.
        • Hiscock R.
        • Decloedt E.H.
        • et al.
        Metformin to treat preterm pre-eclampsia (PI-2): a randomised, double blind, placebo-controlled trial. [Oral concurrent session 3, SMFM 41st Annual Meeting abstract 27].
        Am J Obstet Gynecol. 2021; (S20): 224
        • Paidas M.J.
        • Tita A.T.N.
        • Macones G.A.
        • et al.
        Prospective, randomized, double-blind, placebo-controlled evaluation of the pharmacokinetics, safety and efficacy of recombinant antithrombin versus placebo in preterm preeclampsia.
        Am J Obstet Gynecol. 2020; 223: 739.e1-739.e13
        • Frieden T.R.
        A framework for public health action: the health impact pyramid.
        Am J Public Health. 2010; 100: 590-595
        • Celi A.C.
        • Seely E.W.
        • Wang P.
        • Thomas A.M.
        • Wilkins-Haug L.E.
        Caring for women after hypertensive pregnancies and beyond: implementation and integration of a postpartum transition clinic.
        Matern Child Health J. 2019; 23: 1459-1466
        • Hernandez L.E.
        • Sappenfield W.M.
        • Harris K.
        • et al.
        Pregnancy-related deaths, Florida, 1999–2012: opportunities to improve maternal outcomes.
        Matern Child Health J. 2018; 22: 204-215
        • Triebwasser J.E.
        • Janssen M.K.
        • Hirshberg A.
        • Srinivas S.K.
        Successful implementation of text-based blood pressure monitoring for postpartum hypertension.
        Pregnancy Hypertens. 2020; 22: 156-159
        • Rich-Edwards J.W.
        • Stuart J.J.
        • Skurnik G.
        • et al.
        Randomized trial to reduce cardiovascular risk in women with recent preeclampsia.
        J Womens Health (Larchmt). 2019; 28: 1493-1504
        • Burwick R.M.
        • Feinberg B.B.
        Complement activation and regulation in preeclampsia and hemolysis, elevated liver enzymes, and low platelet count syndrome.
        Am J Obstet Gynecol. 2020; ([Epub ahead of print])
        • Lefkou E.
        • Mamopoulos A.
        • Dagklis T.
        • Vosnakis C.
        • Rousso D.
        • Girardi G.
        Pravastatin improves pregnancy outcomes in obstetric antiphospholipid syndrome refractory to antithrombotic therapy.
        J Clin Invest. 2016; 126: 2933-2940
        • Magee L.A.
        • von Dadelszen P.
        • Rey E.
        • et al.
        Less-tight versus tight control of hypertension in pregnancy.
        N Engl J Med. 2015; 372: 407-417
        • Irgens H.U.
        • Reisaeter L.
        • Irgens L.M.
        • Lie R.T.
        Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study.
        BMJ. 2001; 323: 1213-1217
        • Porcel J.
        • Feigal C.
        • Poye L.
        • et al.
        Hypertensive disorders of pregnancy and risk of screening positive for posttraumatic stress disorder: a cross-sectional study.
        Pregnancy Hypertens. 2013; 3: 254-260
        • Seely E.W.
        • Celi A.C.
        • Chausmer J.
        • et al.
        Cardiovascular health after preeclampsia: patient and provider perspective.
        J Womens Health (Larchmt). 2021; 30: 305-313
        • Seely E.W.
        • Rich-Edwards J.
        • Lui J.
        • et al.
        Risk of future cardiovascular disease in women with prior preeclampsia: a focus group study.
        BMC Pregnancy Childbirth. 2013; 13: 240
      4. ACOG Committee Opinion no. 736: optimizing postpartum care.
        Obstet Gynecol. 2018; 131: e140-e150
        • Smith G.N.
        The Maternal Health Clinic: improving women’s cardiovascular health.
        Semin Perinatol. 2015; 39: 316-319
        • Emergency Nurses Association, Association of Women’s Health, Obstetric and Neonatal Nurses
        Emergency care for patients during pregnancy and the postpartum period: Emergency Nurses Association and Association of Women’s Health, Obstetric and Neonatal Nurses consensus statement.
        (Available at:) (Accessed June 17, 2021)